Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Apple
AAPL
|
+$1.18B |
| 2 |
Microsoft
MSFT
|
+$1.11B |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$491M |
| 4 |
Technology Select Sector SPDR Fund
XLK
|
+$464M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$442M |
Top Sells
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.2B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$779M |
| 3 |
DuPont de Nemours
DD
|
+$443M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$359M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| 1 | Technology | 22.43% |
| 2 | Financials | 13.7% |
| 3 | Consumer Discretionary | 10.25% |
| 4 | Communication Services | 9.85% |
| 5 | Healthcare | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Vanguard Communication Services ETF
VOX
$5.89B
| $1.57M | ﹤0.01% |
+12,048
| New | +$1.57M |
|
|
EPZM
2027
DELISTED
Epizyme, Inc
EPZM
| $1.57M | ﹤0.01% |
179,752
+44,042
| +32% | +$384K |
|
|
IMLP
2028
DELISTED
iPath S&P MLP ETN
IMLP
| $1.56M | ﹤0.01% |
140,000
-10,000
| -7% | -$111K |
|
2029
Clean Harbors
CLH
$12.7B
| $1.55M | ﹤0.01% |
18,449
+7,445
| +68% | +$626K |
|
2030
Preferred Bank
PFBC
$1.16B
| $1.55M | ﹤0.01% |
24,365
+5,730
| +31% | +$365K |
|
|
CNST
2031
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $1.55M | ﹤0.01% |
66,271
-34,302
| -34% | -$802K |
|
|
GTY
2032
Getty Realty Corp
GTY
$1.6B
| $1.54M | ﹤0.01% |
54,472
+6,368
| +13% | +$180K |
|
2033
iShares Global Tech ETF
IXN
$5.93B
| $1.54M | ﹤0.01% |
30,054
-12,600
| -30% | -$646K |
|
2034
Employers Holdings
EIG
$983M
| $1.54M | ﹤0.01% |
35,750
+3,668
| +11% | +$158K |
|
2035
Banco Santander
SAN
$149B
| $1.54M | ﹤0.01% |
447,925
+286,332
| +177% | +$983K |
|
2036
Cohen & Steers
CNS
$3.65B
| $1.54M | ﹤0.01% |
23,506
+9,203
| +64% | +$601K |
|
2037
AMERISAFE
AMSF
$841M
| $1.53M | ﹤0.01% |
23,971
+2,606
| +12% | +$167K |
|
|
AXNX
2038
DELISTED
Axonics, Inc. Common Stock
AXNX
| $1.53M | ﹤0.01% |
25,547
+14,981
| +142% | +$897K |
|
|
GMRE
2039
Global Medical REIT
GMRE
$512M
| $1.53M | ﹤0.01% |
116,696
+38,307
| +49% | +$502K |
|
2040
Cushman & Wakefield
CWK
$3.85B
| $1.52M | ﹤0.01% |
93,142
+53,445
| +135% | +$873K |
|
2041
PJT Partners
PJT
$4.47B
| $1.52M | ﹤0.01% |
22,475
+13,904
| +162% | +$941K |
|
2042
First Trust US Equity Opportunities ETF
FPX
$1.09B
| $1.52M | ﹤0.01% |
+12,729
| New | +$1.52M |
|
2043
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.46B
| $1.52M | ﹤0.01% |
20,769
+19,388
| +1,404% | +$1.42M |
|
|
GAZ
2044
DELISTED
iPath Series B Bloomberg Natural Gas Total Return Sub-Index ETN
GAZ
| $1.51M | ﹤0.01% |
100,000
| – | – |
|
|
ARGO
2045
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $1.5M | ﹤0.01% |
29,867
+19,390
| +185% | +$975K |
|
|
NBIS
2046
Nebius Group N.V. Class A Ordinary Shares
NBIS
$21.6B
| $1.5M | ﹤0.01% |
23,413
-61,724
| -72% | -$3.95M |
|
2047
Global X Robotics & Artificial Intelligence ETF
BOTZ
$2.88B
| $1.5M | ﹤0.01% |
45,219
+2,740
| +6% | +$90.8K |
|
2048
MSC Industrial Direct
MSM
$5.09B
| $1.5M | ﹤0.01% |
16,602
+9,371
| +130% | +$845K |
|
2049
Clean Energy Fuels
CLNE
$526M
| $1.49M | ﹤0.01% |
108,654
+66,699
| +159% | +$917K |
|
2050
Ambev
ABEV
$35.9B
| $1.49M | ﹤0.01% |
544,053
+102,856
| +23% | +$282K |
|